Abnormal excitability of premotor-motor connections in de novo Parkinson's disease

Brain

Volumn 127, Issue 12, 2004, Pages 2732-2746

  Buhmann, C ^a   Gorsler, A ^a   Baumer T ^a   Hidding, U ^a   Demiralay, C ^a   Hinkelmann, K ^a   Weiller, C ^a,b   Siebner, H R ^b,c   Münchau, Alexander ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b NeuroImage Nord   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Parkinson's disease; Premotor cortex; Premotor motor connections; Repetitive transcranial magnetic stimulation; Transcranial magnetic stimulation

Indexed keywords

DOPAMINE; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MOTOR CORTEX; NERVE CELL PLASTICITY; NERVE EXCITABILITY; PARKINSON DISEASE; PREMOTOR CORTEX; PRIORITY JOURNAL; STRIATONIGRAL DEGENERATION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; ANTIPARKINSON AGENTS; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; LEVODOPA; MAGNETICS; MALE; MIDDLE AGED; MOTOR CORTEX; MOTOR SKILLS; PARKINSON DISEASE;

EID: 10344257567     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh321     Document Type: Article

References (56)

1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12: 366-75.
2. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990; 13: 266-71.
3. Bashir ZI, Collingridge GL. An investigation of depotentiation of long-term potentiation in the CA1 region of the hippocampus. Exp Brain Res 1994; 100: 437-43.
4. Bäumer T, Lange R, Liepert J, Weiller C, Siebner HR, Rothwell JC, et al. Repeated premotor rTMS leads to cumulative plastic changes of motor cortex excitability in humans. Neuroimage 2003a; 20: 550-60.
5. Bäumer T, Rothwell JC, Münchau A. Functional connectivity of the human premotor and motor cortex explored with TMS. Suppl Clin Neurophysiol 2003b; 56: 160-9.
6. Berretta S, Sachs Z, Graybiel AM. Cortically driven Fos induction in the striatum is amplified by local dopamine D2-class receptor blockade. Eur J Neurosci 1999; 11: 4309-19.
7. Brown RG, Marsden CD. Internal versus external cues and the control of attention in Parkinson's disease. Brain 1988; 111: 323-45.
8. Buhmann C, Glauche V, Stürenburg HJ, Oechsner M, Weiller C, Büchel C. Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 2003; 126: 451-61.
9. Catalan MJ, Ishii K, Honda M, Samii A, Hallett M. A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 1999; 122: 483-95.
10. Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997; 48: 1398-403.
11. Civardi C, Cantello R, Asselman P, Rothwell JC. Transcranial magnetic stimulation can be used to test connections to primary motor areas from frontal and medial cortex in humans. Neuroimage 2001; 14: 1444-53.
12. Cunnington R, Lalouschek W, Dirnberger G, Walla P, Lindinger G, Asenbaum S, et al. A medial to lateral shift in pre-movement cortical activity in hemi-Parkinson's disease. Clin Neurophysiol 2001; 112: 608-18.
13. Di Lazzaro V, Restuccia D, Oliviero A, Profice P, Ferrara L, Insola A, et al. Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits. Exp Brain Res 1998; 119: 265-8.
14. Fahn S, Elton RL, Committee of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, editors. Recent developments in Parkinson's disease II. New York: Macmillan; 1987. p. 153-63.
15. Flowers K. Lack of prediction in the motor behaviour of parkinsonism. Brain 1978; 101: 35-52.
16. Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol 1991; 30: 365-74.
17. Gerschlager W, Siebner HR, Rothwell JC. Decreased corticospinal excitability after subthreshold 1 Hz rTMS over lateral premotor cortex. Neurology 2001; 57: 449-55.
18. Ghosh S, Porter R. Corticocortical synaptic influences on morphologically indentified pyramidal neurones in the motor cortex of the monkey. J Physiol 1988; 400: 617-29.
19. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-52.
20. Hanakawa T, Fukuyama H, Katsumi Y, Honda M, Shibasaki H. Enhanced lateral premotor activity during paradoxical gait in Parkinson's disease. Ann Neurol 1999; 45: 329-36.
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-42.
22. Ichise M, Kim YJ, Ballinger JR, Vines D, Erami SS, Tanaka F, et al. SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD. Neurology 1999; 52: 1206-14.
23. Jones EG. Laminar distribution of cortical efferent cells. In: Peters A, Jones EG, editors. Cerebral cortex. Vol 1. New York: Plenum Press; 1984. p. 521-53.
24. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993; 471: 501-19.
25. Liepert J, Schwenkreis P, Tegenthoff M, Malin JP. The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm 1997; 104: 1207-14.
26. Marsden CD. Parkinson's disease. J Neurol Neurosurg Psychiatry 1994; 57: 672-81.
27. Münchau A, Bloem BR, Irlbacher K, Trimble MR, Rothwell JC. Functional connectivity of human premotor and motor cortex explored with repetitive transcranial magnetic stimulation. J Neurosci 2002; 22: 554-61.
28. Nicola SM, Surmeier J, Malenka RC. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 2000; 23: 185-215.
29. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97-113.
30. Paule MG, Gillam MP, Morris P. The effects of cocaine on nonhuman primate brain function are age dependent. Ann NY Acad Sci 1998; 844: 178-82.
31. Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 2003; 6: 501-6.
32. Pierantozzi M, Palmieri MG, Marciani MG, Bernardi G, Giacomini P, Stanzione P. Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study. Exp Brain Res 2001; 141: 52-62.
33. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992; 32: 151-61.
34. Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, Marc-Vergnes JP, et al. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 1992; 49: 144-8.
35. Reis J, Tergau F, Hamer HM, Muller HH, Knake S, Fritsch B, et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 2002; 43: 1149-56.
36. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995; 37: 181-8.
37. Rizzo V, Siebner HR, Modugno N, Pesenti A, Münchau A, Gerschlager W, et al. Shaping the excitability of human motor cortex with premotor rTMS. J Physiol 2004; 554: 483-95.
38. Rizzolatti G, Luppino G, Matelli M. The organization of the cortical motor system: new concepts. Electroencephalogr Clin Neurophysiol 1998; 106: 283-96.
39. Rowe J, Stephan KE, Friston K, Frackowiak R, Lees A, Passingham R. Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions. Brain 2002; 125: 276-89.
40. Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 2000; 123: 394-403.
41. Samuel M, Ceballos-Baumann AO, Blin J, Uema T, Boecker H, Passingham RE, et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 1997; 120: 963-76.
42. Schwenkreis P, Liepert J, Witscher K, Fischer W, Weiller C, Malin JP, et al. Riluzole suppresses motor cortex facilitation in correlation to its plasma level. A study using transcranial magnetic stimulation. Exp Brain Res 2000; 135: 293-9.
43. Seamans JK, Gorelova N, Durstewitz D, Yang CR. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 2001; 21: 3628-38.
44. Sesack SR, Hawrylak VA, Melchitzky DS, Lewis DA. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. Cereb Cortex 1998; 8: 614-22.
45. Shimazu H, Maier MA, Cerri G, Kirkwood PA, Lemon RN. Macaque ventral premotor cortex exerts powerful facilitation of motor cortex outputs to upper limb motoneurons. J Neurosci 2004; 24: 1200-11.
46. Siebner HR, Lang N, Rizzo V, Nitsche MA, Paulus W, Lemon RN, et al. Preconditioning of low-frequency repetitive transcranial magnetic stimulation with transcranial direct current stimulation: evidence for homeostatic plasticity in the human motor cortex. J Neurosci 2004; 24: 3379-85.
47. Sloper JJ. An electron microscope study of the termination of afferent connections to the primate motor cortex. J Neurocytol 1973; 2: 361-8.
48. Smith MJ, Keel JC, Greenberg BD, Adams LF, Schmidt PJ, Rubinow DA, et al. Menstrual cycle effects on cortical excitability. Neurology 1999; 53: 2069-72.
49. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM. Effects of ovarian hormones on human cortical excitability. Ann Neurol 2002; 51: 599-603.
50. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21: RC157.
51. Tokuno H, Nambu A. Organization of nonprimary motor cortical inputs on pyramidal and nonpyramidal tract neurons of primary motor cortex: An electrophysiological study in the macaque monkey. Cereb Cortex 2000; 10: 58-68.
52. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998; 108: 1-16.
53. Wise SP, Boussaoud D, Johnson PB, Caminiti R. Premotor and parietal cortex: corticocortical connectivity and combinatorial computations. Annu Rev Neurosci 1997; 20: 25-42.
54. Ziemann U, Bruns D, Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci Lett 1996; 208: 187-90.
55. Ziemann U, Tergau F, Bruns D, Baudewig J, Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 1997; 105: 430-7.
56. Ziemann U, Chen R, Cohen LG, Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998; 51: 1320-4.